Authors:
MUHONEN T
JANTUNEN I
PERTOVAARA H
VOUTILAINEN L
MAICHE A
BLOMQVIST C
PYRHONEN S
KELLOKUMPULEHTINEN P
Citation: T. Muhonen et al., PROPHYLACTIC FILGRASTIM (G-CSF) DURING MITOMYCIN-C, MITOXANTRONE, ANDMETHOTREXATE (MMT) TREATMENT FOR METASTATIC BREAST-CANCER - A RANDOMIZED STUDY, American journal of clinical oncology, 19(3), 1996, pp. 232-234
Authors:
KELLOKUMPULEHTINEN P
JANTUNEN I
FLANDER M
JOHANSSON R
NORDMAN E
Citation: P. Kellokumpulehtinen et al., COMBINED INTERFERON AND VINBLASTINE TREATMENT IN ADVANCED RENAL-CELL CANCER, Acta oncologica, 34(7), 1995, pp. 975-977
Citation: I. Jantunen et T. Muhonen, 5-HT3 RECEPTOR ANTAGONISTS IN THE PROPHYLAXIS OF ACUTE VOMITING INDUCED BY MODERATELY EMETOGENIC CHEMOTHERAPY - A RANDOMIZED STUDY, European journal of cancer, 30A(7), 1994, pp. 1041-1042
Authors:
VUORISTO M
JANTUNEN I
PYRHONEN S
MUHONEN T
KELLOKUMPULEHTINEN P
Citation: M. Vuoristo et al., A COMBINATION OF SUBCUTANEOUS RECOMBINANT INTERLEUKIN-2 AND RECOMBINANT INTERFERON-ALPHA IN THE TREATMENT OF ADVANCED RENAL-CELL CARCINOMA OR MELANOMA, European journal of cancer, 30A(4), 1994, pp. 530-532